Human CD151 Protein, Flag,His Tag (Detergent)
分子别名(Synonym)
EBS7, GP27, MER2, PETA-3, RAPH, SFA1, TSPAN24
表达区间及表达系统(Source)
Human CD151 Protein, Flag,His Tag (CD1-H52D3) is expressed from human 293 cells (HEK293). It contains AA Gly 2 - Tyr 253 (Accession # P48509).
Predicted N-terminus: Met
蛋白结构(Molecular Characterization)

This protein carries flag tag at the N-terminus and polyhistidine tag at the C-terminus.
The protein has a calculated MW of 32.2 kDa.
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
制剂(Formulation)
This product is not suitable for cell based experiments due to cytotoxicity of DDM.
DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumastance should you remove DDM and CHS.
DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
If glycerol is not compatible to your application, remove glycerol just before immediate experiment, and NEVER store glycerol-free protein solution.
Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.
Contact us for customized product form or formulation.
运输(Shipping)
This product is supplied and shipped with dry ice, please inquire the shipping cost.
存储(Storage)
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
The product MUST be stored at -70°C or lower upon receipt;
-70°C for 3 months under sterile conditions.

背景(Background)
该基因编码的蛋白质是跨膜4超家族的成员,也称为tetraspanin家族。这些成员中的大多数是细胞表面蛋白,其特征是存在四个疏水结构域。这些蛋白质介导信号转导事件,在细胞发育、活化、生长和运动的调节中发挥作用。这种编码的蛋白质是一种细胞表面糖蛋白,已知与整合素和其他跨膜4超家族蛋白复合。它参与细胞过程,包括细胞粘附,并可能调节整合素的运输和/或功能。该蛋白增强癌症细胞的运动、侵袭和转移。编码相同蛋白质的多个选择性剪接转录物变体已被描述用于该基因。
关键字: CD151;CD151蛋白;CD151重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。